Location History:
- Hertzlia, IL (2006)
- Herzliya, IL (2010)
Company Filing History:
2 out of 892 
1 out of 2 Years Active: 2006-2010
Title: Dan Grisaru: Innovator in Hematopoietic Cell Differentiation
Introduction
Dan Grisaru is a notable inventor based in Herzliya, Israel. He has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic cell differentiation. With a total of 2 patents, his work has implications for various medical conditions and treatments.
Latest Patents
Grisaru's latest patents include innovative approaches to utilizing acetylcholinesterase (ACHE)-derived peptides. The first patent describes the use of an AChE-R-derived peptide, known as ARP, as an inducer of granulocytopoiesis. This invention outlines methods for promoting hemopoietic cell differentiation and expansion, specifically targeting the granulocytic population. Additionally, it discusses the potential of ARP in pre-transplant priming of hematopoietic stem cells.
The second patent focuses on acetylcholinesterase-derived peptides and their regulatory effects on cell growth and differentiation. This invention includes pharmaceutical compositions that promote the survival, differentiation, and growth of stem cells. It also highlights the use of these peptides in treating conditions such as thrombocytopenia and post-chemotherapy effects. Furthermore, the patent discusses diagnostic applications for antibodies against the peptides, particularly in relation to stress-induced male infertility.
Career Highlights
Throughout his career, Dan Grisaru has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem and the Medical Research Fund at the Tel-Aviv Sourasky Medical Center. His research has significantly advanced the understanding of stem cell biology and therapeutic applications.
Collaborations
Grisaru has collaborated with prominent researchers in his field, including Hermona Soreq and Varda Deutsch. These partnerships have fostered innovative research and development in the biomedical sector.
Conclusion
Dan Grisaru's contributions to the field of hematopoietic cell differentiation through his patents and collaborations highlight his role as a leading inventor in biomedical research. His work continues to pave the way for advancements in medical treatments and therapies.